Colorado study suggests new combination treatment against relapsed head and neck cancer

(University of Colorado Anschutz Medical Campus) 'EphB4-ephrin-B2 inhibitors are currently in clinical trials in other disease settings, and our work shows that it might be successful in combination with EGFR inhibition in advanced head and neck cancers as well,' says Sana Karam, M.D., Ph.D.